In fiscal year 2025, LivsMed (491000) reported revenue of 51.2 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 51.2 billion KRW | -22.6 billion KRW | -22.9 billion KRW | [source] |
| 2024 | 27.1 billion KRW | -26.5 billion KRW | -25.6 billion KRW | — |
| 2023 | 17.3 billion KRW | -23.9 billion KRW | -57.0 billion KRW | — |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 203.1 billion KRW | 20.2 billion KRW | 182.8 billion KRW | [source] |
| 2024 | — | — | — | — |
| 2023 | — | — | — | — |
Cash Flow
| Year | Operating | Investing | Financing | Source |
|---|---|---|---|---|
| 2025 | -34.7 billion KRW | -129.2 billion KRW | 158.4 billion KRW | [source] |
| 2024 | — | — | — | — |
| 2023 | — | — | — | — |
Years without a source link are outside the DART financial API collection period.
Balance sheet figures for the relevant year were not collected.
Cash flow figures for the relevant year were not collected.